Grants.Gov Electronic Application Package Review
NIH Applications
PI:
Title:
General

NIH recommends preparing attachments using any word processing program then converting those
files to PDF. This requires a PDF-creation software such as Adobe Acrobat Professional which is
available at reduced cost to departments through SLU ITS. NIH does not recommend scanning
documents because the scanning process doesn’t preserve document formatting and can hamper
the automated processing.

All yellow highlighted fields in the grants.gov application package are required.

Blue highlighted fields in this checklist represent changes made to the NIH application forms in the
last two years.

Font
o
o
o
o
o
o
Arial, Helvetica, Palatino Linotype, or Georgia typeface
a black font color
a font size of 11 points or larger
Type density, including characters and spaces, no more than 15 characters per inch
Type may be no more than six lines per inch.
For Figures, Graphs, Diagrams, Charts, Tables, Figure Legends, and Footnotes, smaller
type size acceptable, but text color must be black and readily legible, figures can be in
color

Page Margins
o Use standard paper size (8 ½" x 11)
o At least .5 inches (top, bottom, left, and right) for all pages

Page Formatting
o a standard, single-column format for the text, avoid two-column format

ALL FILENAMES:
Save all files with descriptive file names of 50 characters or less and be sure to only use standard
characters in file names: A through Z, a through z, 0 through 9, and underscore (_). Do not use any
special characters (example: “&”, “-“, “*”, “%”, “/”, and “#”) or spacing in the file name, and for word
separation use underscore (example: “My_Attached_File.pdf”) in naming the attachments.

ALL ATTACHMENTS:
All must be pdf format
NO headers
NO footers
NO editable fields

Link to the full grant Application Guide:
Version B and B1: http://grants.nih.gov/grants/funding/424/SF424_RR_Guide_General_Adobe_VerB.pdf
Address note: anytime a unit of Saint Louis University submits and accepts awards from an outside
organization, it is always Saint Louis University (221 N. Grand Blvd., St. Louis, MO 63103-2006) that is
the legal applicant for the award, not the subunit. It's okay to put something like this: Saint Louis
University (Liver Center), or "on behalf of the Liver Center"…
Document1, revised January 2011
Page 1 of 12
SF 424 (R&R)
All fields complete?
There should be no yellow fields
1 – Type of submission
Always “Application”
“Changed/Corrected Application” only used by ORDS
“Preapplication” not used by NIH
2 – Date submitted
Date of submission, can be completed by ORDS
2 – Applicant identifier
Leave blank (can use eRS #)
3 – Date received by state, state application
Leave blank
identifier
4 – Federal Identifier
Blank for new submissions
Resubmissions or Renewals = previously assigned grant
number that includes the 2 letter administering
organization code and the 6 digit serial number (e.g.,
CA123456 or CA012345)
5 – DUNS
050220722
5 – Applicant Information Legal Name
Saint Louis University
5 – Applicant Information address
221 N Grand Blvd, St Louis, [omit the county] MO
63103-2006
5 – Applicant Information Contact
Dr. Sheila Lischwe, Ph.D., Phone 314-977-7742, Fax
314-977-7371, grants@slu.edu
6 – EIN
1430654872A1
7 – Type of Applicant
O: Private Institution of Higher Education
8 – Type of Application
New
Resubmission = Revised application
Renewal = Competing continuation
Continuation is not currently used by NIH
Revision = Competing supplemental
9 – Name of federal agency
Pre-filled
10 – Catalog of federal domestic assistance
Pre-filled or leave blank
number
11 – Descriptive title of applicant’s project
Free text field of PI’s choosing—limit of 81 characters,
Do not use “…” around title (“ characters will including spaces between words [you can check this in
not translate correctly).
MS Word using Tools/Word Count]
12 – Proposed Project
Dates must match dates on budget pages (total project
period)
13 – Congressional Districts of
Applicant = MO-001, Project = MO-001
14 – PI Information
Complete all fields; be sure to correct the zip code
15 – Estimated Project Funding
Must match total of budget on cumulative budget form;
all fields must be filled in; use 0 where necessary
16 – Is application subject to review by State Whether or not the application is subject to this review is
Executive Order 12372 process?
identified in the funding opportunity announcement. If
the application is subject to review, the Office of
Research Services will provide additional assistance.
17 – certification
Check “I agree” to provide the required certifications and
assurances. This field is required.
18. SFLLL or Other Explanatory
If applicable, attach the SFLLL (Standard Form LLL,
Documentation
Disclosure of Lobbying Activities) or other explanatory
document per agency instructions.
19 – Authorized Representative
ORDS representative who will be submitting the
application, usually Dr. Sheila Lischwe, Ph.D.;
Director, Office of Research Development & Services,
3700 West Pine Mall, Fusz Memorial Hall, Room 357,
St. Louis, MO 63108-3306, Phone 314-977-7742, Fax
Document1, revised January 2011
Page 2 of 12
314-977-7371, grants@slu.edu
As of 2/07 Multiple PI’s allowed on: R01, R03, R13/U13, R15, R18/U18, R21, R21/R33, R25, R33, R34, R41, R42, R43,
R44, and C06/UC6; First PI must be affiliated with submitting institution. NIH Notice regarding Multiple PI option:
http://grants1.nih.gov/grants/guide/notice-files/NOT-OD-07-017.html
Research & Related Other Project Information
1 – Human Subjects Assurance Number
00005304
If YES, verify eRS transmittal form
2 – Animal Welfare Assurance Number
A-3225-01
6 – International Activities/Collaborators
If YES, check to see that export controls are answered on
eRS transmittal form
7 – Project Summary/Abstract
Limited to 30 lines of text
8 – Project Narrative
2-3 sentences on relevance to public health (lay language)
9 – Bibliography & References Cited
Please confirm 1) all Pub Med numbers are included on
Include the PMCID number for any
the reference list, and 2) the articles included in the
publications authored or co-authored by
attachment are not freely available online. Pub Med
you, accepted for publication after April 7,
numbers need to be included on all citations where PI is
2008, and that is based on NIH funded
an author or co-author, the article was accepted for
research.
publication after April 7, 2008, and is based on NIH funded
In July 2010 all publications must be
research.
entered in the MY NCBI system, PIs will be
required to have an account in MY NCBI
If PMCID not yet available, check journals on NIH Guide
system that is linked to their eRA
website – “PMC Journal – in progress”
Commons account.
10 – Facilities
New NIH requirement:
On the Facilities page, need a separate
heading to address the Research
Environment.
11 – Equipment
12 – Other Attachments
Describe how the scientific environment in which the
research will be done contributes to the probability of
success (e.g., institutional support, physical resources,
and intellectual rapport). In describing the scientific
environment in which the work will be done, discuss
ways in which the proposed studies will benefit from
unique features of the scientific environment or
subject populations or will employ useful
collaborative arrangements.
NIH does not use this field
Research & Related Senior/Key Person Profile [could be (Expanded) version]
Project Director/Principal Investigator
Credential, e.g., agency logon:
REQUIRED: NIH eRA Commons user name must be
provided in all caps with no punctuation
Degree Type
Enter the highest academic or professional degree or
other credentials (e.g., RN). This is optional information.
Degree Year
Enter the year the highest degree or other credential was
obtained. This is optional information.
Biosketch* (sample below)
Included (PDF file) Biosketch format should follow SF424
Note: New Section for Biosketch
application guidelines. Other formats will not block
A..Personal Statement
submission but it is recommended to be consistent and
Note: Section C, limit publications or
follow application guidelines.
A. Personal Statement.
manuscripts to no more than 15
B. Positions and Honors.
Document1, revised January 2011
Page 3 of 12
Current & Pending Support
C. Peer-reviewed publications or manuscripts in press
(in chronological order). NIH encourages applicants to
limit the list of selected peer-reviewed publications or
manuscripts in press to no more than 15.
D. Research Support. List both selected ongoing and
completed (during the last three years) research projects
(Federal or non-Federal support).
Not provided unless specifically requested in FOA
Research & Related Project/Performance Site Locations
Site 1
Address where project will be conducted
Subaward location also entered here
***A new field has been added to the Project/Performance Site Location(s) form for the Congressional
District of the project. Enter “MO-001”
Person 1
Credential
Organization Name
Project Role
Degree Type
Degree Year
Biosketch* (sample below)
Note: New Section for Biosketch
A. Personal Statement
Note: Section C, limit publications or
manuscripts to no more than 15
Current & Pending Support
Person 2
Credential
Organization Name
Project Role
Degree Type
Degree Year
Biosketch* (sample below)
Note: New Section for Biosketch
A. Personal Statement
Note: Section C, limit publications or
manuscripts to no more than 15
Current & Pending Support
If multiple PI, all person’s designed as “PD/PI” must
provide NIH eRA Commons user name in all caps
Must be included
Not “Co-PI”, see note below; use co-investigator
Enter the highest academic or professional degree or
other credentials (e.g., RN). This is optional information.
Enter the year the highest degree or other credential was
obtained. This is optional information.
Included (PDF file) Biosketch format should follow SF424
application guidelines. Other formats will not block
submission but it is recommended to be consistent and
follow application guidelines.
Not provided unless specifically requested in FOA
If multiple PI, all person’s designed as “PD/PI” must
provide NIH eRA Commons user name in all caps
Must be included
Not “Co-PI”, see note below
Enter the highest academic or professional degree or
other credentials (e.g., RN). This is optional information.
Enter the year the highest degree or other credential was
obtained. This is optional information.
Included (PDF file) Biosketch format should follow SF424
application guidelines. Other formats will not block
submission but it is recommended to be consistent and
follow application guidelines.
Not provided unless specifically requested in FOA
[Note: You may need to copy this section for additional Key Persons.]
* Use the sample format on the Biographical Sketch Format Page to prepare this section for all (modular and other)
grant applications. Include biographical sketches of all Senior/Key Personnel and Other Significant
Contributors. The Biographical Sketch may not exceed four pages per person. This 4-page limit includes the table
at the top of the first page. See the sample of a completed Biographical Sketch BELOW.
Document1, revised January 2011
Page 4 of 12
NIH Grants.Gov Application Guide: If you are submitting an application reflecting Multiple PDs/PIs, all such
individuals must be assigned the PD/PI role. The role of “Co-PD/PI” is not currently used by NIH and other
PHS agencies. Do not assign any individual this role.
Do not use the “Co-PI” role.
Use "Other" if a category is not listed in the pick list.
If applicants wish to use the role of “Co-Investigator” or some other similar role, select “Other” for the
Project Role field and then insert the appropriate role descriptor in the Other Project Role Category field.
If you are submitting an application reflecting Multiple PD/PIs, all such individuals must be assigned the
PD/PI role, even those at organizations other than the applicant organization. Projects with multiple PI’s
require a Leadership Plan attached to Research Plan (item 11).
1 – Application type
2 – Research Plan Attachments: All
must be PDF files.
PHS 398 Research Plan
Pre-filled from SF424
1 – Introduction to Application—for
Resubmission or Revision only
2 – Specific Aims
3 – Research Strategy
Follow the page limits for the Research
Strategy in the table of page limits (Table
2.6-1 below), unless specified otherwise in
the FOA. Note that the page limit for this
attachment will be validated as a single
file.
6 – Protection of Human Subjects
7 – Women and Minorities
8 – Targeted/Planned Enrollment
9 – Inclusion of Children
10 – Vertebrate Animals
11- Select Agent Research (NEW)
Describe any special facilities used for
working with biohazards or other
potentially dangerous substances.
12 – Leadership Plan
13 – Consortium
14 – Letters of Support
15 – Resource sharing plan(s)
Document1, revised January 2011
Acceptable characters in filenames: hyphen, underscore,
period
NO spaces, brackets or other special characters
Please observe specified page limit, often one page.
Specific Aims are limited to one page.
Organize the Research Strategy in the specified order and
using the instructions. Start each section with the
appropriate section heading – Significance, Innovation,
Approach. Do not include page numbers, color text, or
embedded hyperlinks.
Research Strategy (Item
5.5.3 of Research Plan)
For Activity Codes R03, R13,
R21, R36, SC2, SC3
6 pages
Research Strategy (Item
5.5.3 of Research Plan)
For Activity Codes R01, R10,
R15, R18, R21/R33, R24,
R33, R34, DP3, G08, G11,
G13, SC1, X01
12 pages
Required if Human Subjects are involved
Required if Human Subjects are involved
Required if Human Subjects are involved
Required if Human Subjects are involved
Required if Vertebrate Animals are involved
Provide a description of all facilities where the Select
Agent(s) will be used.
• Describe the procedures that will be used to monitor
possession, use and transfer of the Select Agent(s).
• Describe plans for appropriate biosafety, biocontainment,
and security of the Select Agent(s).
• Describe the biocontainment resources available at all
performance sites.
Required for multiple PI’s
Required for detailed budget with Subaward
Page 5 of 12
16 – Appendix—see reference below 
Please make sure that the publications included in the
Appendix are not freely available online to the public.
Only one copy of appendix material is necessary. A
maximum of 10 PDF attachments is allowed in the
Appendix. If more than 10 appendix attachments are
needed, combine the remaining information into
attachment #10. Note that this is the total number of
appendix items, not the total number of publications. When
allowed there is a limit of 3 publications that are not
publicly available (see below for further details and check
the FOA for any specific instructions), though not all grant
activity codes allow publications to be included in the
appendix.
NIH Notice regarding Appendix materials:
http://grants2.nih.gov/grants/guide/notice-files/NOT-OD-07-018.html
PHS 398 Cover Page Supplement
3 – Applicant Organization Contact
Dr. Sheila Lischwe and ORDS address (see above)
4 – Human Embryonic Stem Cells
Must be completed—check “No.”
1 – Application type
2 – Change of investigator/Change of
institution
3 – Inventions and patents
4 – Program Income
5 – Disclosure Permission Statement
PHS 398 Checklist
Pre-filled from SF424
Only if applicable
For renewals only
Answer
Required
PHS 398Cover Letter File
Optional (recommended) in new submissions;
To be read by NIH officials, not reviewers
required in certain cases.
Recommend letter on SLU letterhead with PI
signature.
PHS 398 Modular Budget
General: All budget periods must be identified. Project dates must match SF424
General: project dates
Must match SF424
Budget period Start and End date
All budget periods must be identified
B. Indirect Costs
50% MTDC (modified total direct costs)
B. Cognizant Agency
U.S. DHHS, Arif Karim 214-767-3261
– identified for each budget period
B. Indirect Cost Rate Agreement Date
01/05/2011 – identified for each budget period
2. Personnel Justification PDF file
Express effort in person months and indicate
whether Calendar, Academic, or Summer
months.
2. Consortium Justification PDF file
If applicable.
2. Additional Narrative Justification PDF file
Provide explanation if modules vary from year to
If international travel is/may be involved please state:
year.
“This proposal will include international travel.” or
“There is a possibility that this proposal will include
international travel to (Country) for (purpose).”
Document1, revised January 2011
Page 6 of 12
NIH Grants.Gov Application Guide: The modular budget is applicable only to R01, R03, R15, R21, and R34 applications. (pg.
95)
Research & Related Budget
General: project dates
Must match SF424
Budget period Start and End date
All budget periods must be identified
H. Indirect Costs
Type is MTDC; Rate is 50 (%)
H. Cognizant Federal Agency
U.S. DHHS, Arif Karim 214-767-3261
– identified for each budget period
K. Budget Justification one PDF file
For each budget period, you must attach the
same budget justification (for entire project) to be
allowed to enter the next budget period.
R&R Subaward Budget Attachment(s) Form
Subaward Attachments
Save the attachment using the first 10 letters of
the consortium organization’s name as the
filename.
Project Period
Correctly identified
H. Indirect Costs identified
Identified
H. Cognizant Federal Agency
Identified
K. Budget Justification
For each budget period, attach the budget
justification for entire project
NIH Grants.Gov Application Guide: Note, a complete subaward/consortium budget component is only
required when the prime grantee is submitting a detailed budget using the R&R Budget Component.
URL Note:
All applications and proposals for NIH and other PHS agency funding must be self-contained within
specified page limitations. Unless otherwise specified in an NIH solicitation, Internet website addresses
(URLs) may not be used to provide information necessary to the review because reviewers are under no
obligation to view the Internet sites. Moreover, reviewers are cautioned that they should not directly
access an Internet site as it could compromise their anonymity.
Resubmission Note:
There are four requirements for a Resubmission application:
The Summary Statement must be available in the eRA Commons
(http://commons.era.nih.gov/commons).
The PD/PI(s) must make significant changes to the application.
An Introduction must be included that summarizes the substantial additions, deletions, and
changes to the application. The Introduction must also include a response to the issues and
criticism raised in the Summary Statement. The Introduction is separate from the Cover
Letter. Use Item 2.1 Introduction of the PHS398 Research Plan Component to provide this
information. Page limits for the Introduction should not exceed three pages unless the FOA
specifies otherwise.
The substantial scientific changes must be marked in the text of the application by bracketing,
indenting, or change of typography. Do not underline or shade the changes. Deleted sections
should be described but not marked as deletions. If the changes are so extensive that
essentially all of the text would be marked, explain this in the Introduction. The Preliminary
Document1, revised January 2011
Page 7 of 12
Studies/Progress Report section should incorporate work completed since the prior version of
the application was submitted.
ADDITIONAL SLU PAPERWORK NEEDED
WHEN APPLICATION INCLUDES CONSORTIUM
If SLU is submitting prime application using Modular Budget the following items are needed from
each subcontractor:
1. ONE of these three items:
SF 424 (R&R) cover page signed by an institutional official of subcontractor
OR
PHS 398 Face Page signed by an institutional official of subcontractor
OR
Letter of intent to establish consortium signed by an institutional official of subcontractor
AND one of these two items:
2. Research & Related Budget Form from Grants.Gov electronic application package, including budget
justification
OR
PHS 398 Form, pp. 4 & 5 & Checklist Page, including budget justification
AND:
3. Brief statement of work from consortium site.
OR
If SLU is submitting prime application using Detailed Budget the following items are needed from
each subcontractor--you need all three of the following:
1. Letter of intent to establish consortium signed by institutional official of subcontractor
2. Research & Related Budget Form from Grants.Gov electronic application package, including budget
justification
3. Brief statement of work from consortium site.
Document1, revised January 2011
Page 8 of 12
Table 2.6-1. Page Limits SECTION OF
APPLICATION
Also refer to the relevant section of the
application instructions and the FOA.
Introduction to Resubmission Application
(3 pages for R25 on PHS398 Research Plan and
3 pages for K12, T and D Training Grants on
PHS398 Training Program Plan)
Introduction to Revision Application
Specific Aims
Research Strategy (Item 5.5.3 of Research
Plan)
For Activity Codes R03, R13, R21, R36, SC2,
SC3
Research Strategy (Item 5.5.3 of Research
Plan)
For Activity Codes R01, R10, R15, R18,
R21/R33, R24, R33, R34, DP3, G08, G11, G13,
SC1, X01
Research Strategy (Item 5.5.3 of Research
Plan)
For all other Activity Codes, including S Activity
Codes
Research Education Program Plan
For R25 Research Education Grant Applications
Biosketch (per person)
(2 pages for DP1 and DP2 Activity Codes)
Career Development Award (K) Application
Upload to PHS 398 Career Development Award
Supplemental Form: Combined Candidate
Information (Items 3-5: Candidate’s Background,
Career Goals and Objectives, Career
Development/Training Activities During Award
Period, and Training on the Responsible Conduct
of Research) and Research Strategy (Item 11)
Institutional Research Training and Career
Development Applicants, Including Ruth L.
Kirschstein NRSA Application
Research Training Program Plan: Combined
Sections 8.7.2.2 – 8.7.2.5 (Background, Program
Plan, Recruitment and Retention Plan to
Enhance Diversity, and Plan for Instruction in the
Responsible Conduct of Research)
PAGE LIMITS *
1 page
1 page
1 page
6 pages
12 pages
Follow FOA instructions
25 pages
4 pages
12 pages
25 pages
* FOA instructions always supersede these instructions.
Document1, revised January 2011
Page 9 of 12
SAMPLE NIH BIOSKETCH (NEW FOR JANUARY 2010)
BIOGRAPHICAL SKETCH
Provide the following information for the Senior/key personnel and other significant contributors.
Follow this format for each person. DO NOT EXCEED FOUR PAGES.
NAME
POSITION TITLE
Hunt, Virginia Lively
Associate Professor of Psychology
eRA COMMONS USER NAME (credential, e.g.,
agency login)
huntvl
EDUCATION/TRAINING (Begin with baccalaureate or other initial professional education, such as nursing, include
postdoctoral training and residency training if applicable.)
INSTITUTION AND LOCATION
University of California, Berkeley
University of Vermont
University of California, Berkeley
DEGREE
(if
applicable)
B.S.
MM/YY
FIELD OF STUDY
05/90
Psychology
Ph.D.
05/96
Experimental
Psychology
Postdoctoral
08/98
Public Health and
Epidemiology
A. Personal Statement
The goal of the proposed research is to investigate the interaction between drug abuse and normal aging
processes. Specifically, we plan to measure changes in cognitive ability and mental and physical health
across a five-year period in a group of older drug users and matched controls. I have the expertise,
leadership and motivation necessary to successfully carry out the proposed work. I have a broad
background in psychology, with specific training and expertise in key research areas for this application.
As a postdoctoral fellow at Berkeley, I carried out ethnographic and survey research and secondary data
analysis on psychological aspects of drug addiction. At the Division of Intramural Research at the
National Institute on Drug Abuse (NIDA), I expanded my research to include neuropsychological changes
associated with addiction. As PI or co-Investigator on several previous university- and NIH-funded
grants, I laid the groundwork for the proposed research by developing effective measures of disability,
depression, and other psychosocial factors relevant to the aging substance abuser, and by establishing
strong ties with community providers that will make it possible to recruit and track participants over time.
In addition, I successfully administered the projects (e.g. staffing, research protections, budget),
collaborated with other researchers, and produced several peer-reviewed publications from each project.
As a result of these previous experiences, I am aware of the importance of frequent communication
among project members and of constructing a realistic research plan, timeline, and budget. The current
application builds logically on my prior work, and I have chosen co-investigators (Drs. Gryczynski and
Newlin) who provide additional expertise in cognition, gerontology and geriatrics. In summary, I have a
demonstrated record of successful and productive research projects in an area of high relevance for our
aging population, and my expertise and experience have prepared me to lead the proposed project.
Document1, revised January 2011
Page 10 of 12
B. Positions and Honors
Positions and Employment
1998-2000
Fellow, Division of Intramural Research, National Institute of Drug Abuse,
Bethesda, MD
2000-2002
Lecturer, Department of Psychology, Middlebury College, Middlebury, VT
2001Consultant, Coastal Psychological Services, San Francisco, CA
2002-2005
Assistant Professor, Department of Psychology, Washington University, St. Louis,
MO
2005Associate Professor, Department of Psychology, Washington University, St. Louis,
MO
Other Experience and Professional Memberships
1995Member, American Psychological Association
1998Member, Gerontological Society of America
1998Member, American Geriatrics Society
2000Associate Editor, Psychology and Aging
2003Board of Advisors, Senior Services of Eastern Missouri
2003-04
NIH Peer Review Committee: Psychobiology of Aging, ad hoc reviewer
2005-09
NIH Risk, Adult Addictions Study Section, member
Honors
2003
2005
2008
Outstanding Young Faculty Award, Washington University, St. Louis, MO
Excellence in Teaching, Washington University, St. Louis, MO
Award for Best in Interdisciplinary Ethnography, International Ethnographic Society
C. Selected Peer-reviewed Publications (Selected from 42 peer-reviewed publications)
Most relevant to the current application
1. Merryle, R.J. & Hunt, V.L. (2004). Independent living, physical disability and substance abuse among
the elderly. Psychology and Aging, 23(4), 10-22.
2. Hunt, V.L, Jensen, J.L. & Crenshaw, W. (2007). Substance abuse and mental health among
community-dwelling elderly. International Journal of Geriatric Psychiatry, 24(9), 1124-1135.
3. Hunt, V.L, Wiechelt, S.A. & Merryle, R. (2008). Predicting the substance-abuse treatment needs of
an aging population. American Journal of Public Health, 45(2), 236-245. PMCID: PMC9162292
4. Hunt, V.L., Newlin, D.B. & Fishbein, D. (2009). Brain imaging in methamphetamine abusers across
the life-span. Gerontology, 46(3), 122-145.
5. Hunt, V.L. & Sher, K.A. (2009). Successful intervention models for older drug-abusers: Research
across the life-span. American Psychologist, in press. NIHMSID: NIHMS99135
Additional recent publications of importance to the field (in chronological order)
1. Gryczynski, J., Shaft, B.M., Merryle, R., & Hunt, V.L. (2002). Community based participatory research
with late-life addicts. American Journal of Alcohol and Drug Abuse, 15(3), 222-238.
2. Shaft, B.M., Hunt, V.L., Merryle, R., & Venturi, R. (2003). Policy implications of genetic transmission
of alcohol and drug abuse in female nonusers. International Journal of Drug Policy, 30(5), 46-58.
3. Hunt, V. L., Marks, A.E., Shaft, B.M., Merryle, R., & Jensen, J.L. (2004). Early-life family and
community characteristics and late-life substance abuse. Journal of Applied Gerontology, 28(2),2637.
4. Hunt, V.L., Merryle, R. & Jensen, J.L. (2005). The effect of social support networks on morbidity
among elderly substance abusers. Journal of the American Geriatrics Society, 57(4), 15-23.
5. Hunt, V.L., Pour, B., Marks, A.E., Merryle, R. & Jensen, J.L. (2005). Aging out of methadone
treatment. American Journal of Alcohol and Drug Abuse, 15(6), 134-149.
Document1, revised January 2011
Page 11 of 12
6. Hunt, V.L, Marks, A.E., Venturi, R., Crenshaw, W. & Ratonian, A. (2006). Community-based
intervention strategies for reducing alcohol and drug abuse in the elderly. Addiction, 104(9), 14361606. PMCID: PMC9000292
7. Merryle, R. & Hunt, V.L. (2006). Randomized clinical trial of cotinine in older nicotine addicts. Age
and Ageing, 38(2), 9-23. PMCID: PMC9002364
8. Hunt, V.L., Jensen, J.L. & Merryle, R. (2008). The aging addict: ethnographic profiles of the elderly
drug user. NY, NY: W. W. Norton & Company.
9. Hunt, V.L. (2009). Contrasting ethnicity with race in the older alcoholic. TheJournals of Gerontology
Series B: Psychological Sciences and Social Sciences, in press. PMCID: PMC Journal – In Process.
10. Hunt, V.L. (2009). Intervening successfully with the older methadone patient. Journal of Applied
Gerontology, 13(4), 67-79.
D. Research Support
Ongoing Research Support
R01 DA942367-03
Hunt (PI)
09/01/0708/31/12
Health trajectories and behavioral interventions among older substance abusers
The goal of this study is to compare the effects of two substance abuse interventions on health outcomes
in an urban population of older opiate addicts.
Role: PI
R01 MH922731-05
Merryle (PI)
07/15/05-06/30/10
Physical disability, depression and substance abuse in the elderly
The goal of this study is to identify disability and depression trajectories and demographic factors
associated with substance abuse in an independently-living elderly population.
Role: Co-Investigator
Faculty Resources Grant, Washington University
08/15/09-08/14/11
Opiate Addiction Database
The goal of this project is to create an integrated database of demographic, social and biomedical
information for homeless opiate abusers in two urban Missouri locations, using a number of state and
local data sources.
Completed Research Support
K02 AG442898
Hunt (PI)
09/01/06-08/31/09
Drug Abuse in the Elderly
Independent Scientist Award: to develop a drug addiction research program with a focus on substance
abuse among the elderly.
Role: PI
R21 AA998075
Hunt (PI)
01/01/04-12/31/06
Community-based intervention for alcohol abuse
The goal of this project was to assess a community-based strategy for reducing alcohol abuse among
older individuals.
Role: PI
Document1, revised January 2011
Page 12 of 12